Notice2024-09591
Notice of Diabetes Mellitus Interagency Coordinating Committee Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
May 3, 2024
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Abstract
The Diabetes Mellitus Interagency Coordinating Committee (DMICC) will hold a meeting on May 30, 2024. The topic for this meeting will be "Artificial Intelligence in Diabetes Precision Medicine: Real world data, real world opportunities and challenges". The meeting is open to the public.
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 87 (Friday, May 3, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 87 (Friday, May 3, 2024)]
[Notices]
[Pages 36825-36826]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-09591]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Notice of Diabetes Mellitus Interagency Coordinating Committee
Meeting
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Diabetes Mellitus Interagency Coordinating Committee
(DMICC) will hold a meeting on May 30, 2024. The topic for this meeting
will be ``Artificial Intelligence in Diabetes Precision Medicine: Real
world data, real world opportunities and challenges''. The meeting is
open to the public.
DATES: The meeting will be held on May 30, 2024 from 12:00 p.m. to 3:30
p.m. EDT.
ADDRESSES: The meeting will be held via the Zoom online video
conferencing platform. For details, and to register, please contact
<a href="/cdn-cgi/l/email-protection#781c15111b1b381519111456161110561f170e"><span class="__cf_email__" data-cfemail="5430393d37371439353d387a3a3d3c7a333b22">[email protected]</span></a>.
FOR FURTHER INFORMATION CONTACT: For further information concerning
this meeting, including a draft agenda, which will be posted when
available, see the DMICC website, <a href="https://www.niddk.nih.gov/about-niddk/advisory-coordinating-committees/diabetes-mellitus-interagency-coordinating-committee-dmicc?dkrd=lgdmn0022">https://www.niddk.nih.gov/about-niddk/advisory-coordinating-committees/diabetes-mellitus-interagency-coordinating-committee-dmicc?dkrd=lgdmn0022</a>, or contact Dr. William
Cefalu, Executive Secretary of the Diabetes Mellitus Interagency
Coordinating Committee, National Institute of Diabetes and Digestive
and Kidney Diseases, 6707 Democracy Boulevard, Democracy 2, Room 6037,
Bethesda, MD 20892, telephone: 301-435-1011; email: <a href="/cdn-cgi/l/email-protection#07636a6e6464476a666e6b29696e6f29606871"><span class="__cf_email__" data-cfemail="2c4841454f4f6c414d454002424544024b435a">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: In accordance with 42 U.S. Code 285c-3, the
DMICC, chaired by the National Institute of Diabetes and Digestive and
Kidney Diseases (NIDDK) comprising members of the Department of Health
and Human Services and other federal agencies that support diabetes-
related activities, facilitates cooperation, communication, and
collaboration on diabetes among government entities. DMICC meetings,
held several times a year, provide an opportunity for Committee members
to learn about and discuss current and future diabetes programs in
DMICC member organizations and to identify opportunities for
collaboration. The May 30, 2024 DMICC meeting will focus on
``Artificial Intelligence in Diabetes Precision Medicine: Real world
data, real world opportunities and challenges.''
Any member of the public interested in presenting oral comments to
the Committee should notify the contact person listed on this notice at
least 5 days in advance of the meeting. Interested individuals and
representatives or organizations should submit a letter of intent, a
brief description of the organization represented, and a written copy
of their oral presentation in advance of the
[[Page 36826]]
meeting. Only one representative of an organization will be allowed to
present; oral comments and presentations will be limited to a maximum
of 5 minutes. Printed and electronic copies are requested for the
record. In addition, any interested person may file written comments
with the Committee by forwarding their statement to the contact person
listed on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person. Because of time constraints for
the meeting, oral comments will be allowed on a first-come, first-serve
basis.
Members of the public who would like to receive email notification
about future DMICC meetings should register for the listserv available
on the DMICC website, <a href="https://www.niddk.nih.gov/about-niddk/advisory-coordinating-committees/diabetes-mellitus-interagency-coordinating-committee-dmicc?dkrd=lgdmn0022">https://www.niddk.nih.gov/about-niddk/advisory-coordinating-committees/diabetes-mellitus-interagency-coordinating-committee-dmicc?dkrd=lgdmn0022</a>.
William T. Cefalu,
Director, Division of Diabetes, Endocrinology, and Metabolic Diseases,
National Institute of Diabetes and Digestive and Kidney Diseases, and
Metabolic Diseases, National Institutes of Health.
[FR Doc. 2024-09591 Filed 5-2-24; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on May 3, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.